Efficacy of novel Antidiabetic drug (dual GIP and GLP-1 re | UPDATES IN MEDICINE
Efficacy of novel Antidiabetic drug (dual GIP and GLP-1 receptor agonist) TRZEPATIDE in type 2 diabetes (SURPASS-1 trial)
● Interpretation - Tirzepatide showed robust improvements in glycaemic control and bodyweight, without increased risk of hypoglycaemia. The safety profile was consistent with GLP-1 receptor agonists, indicating a potential monotherapy use of tirzepatide for type 2 diabetes treatment. #endocrinology #diabetes
